Board-certified urologist Bela Denes trained at Washington University in St. Louis, Missouri. With 25 years of clinical and academic experience Bela now leads the Genomic Health Medical Affairs team as the Senior Director of Urology. In an interview on this site he discusses the Oncotype DX Prostate Cancer Assay, one of the new tests using advanced genomic methods. This test examines the activity level of 17 genes from a biopsy sample and computes a score from 0 to 100, distinguishing aggressive prostate cancer from less threatening prostate cancer. The test results provide useful information for men considering or already following an active surveillance regimen, and for other patients as well.
Karen Kunz, BSN, C.U.R.N., is a certified urology nurse at Myriad Genetics. As the wife of a prostate cancer patient Karen is committed to helping improve the lives of men with prostate cancer. In a video interview on this site Karen describes the Myriad Genetics Prolaris test where genetic information from biopsy tissue samples produces data about the potential aggressiveness or lack of aggressiveness of the cancer cells. Prolaris test results are particularly useful when considering immediate treatment or active surveillance.
Dr. Snuffy Myers
Medical oncologist and prostate cancer patient, Dr. Charles “Snuffy” Myers served for 10 years as Chief of the Clinical Pharmacy Branch at the National Cancer Institute. From 1994 to 2002 Snuffy was Director of the Cancer Center at the University of Virginia. His research group demonstrated that a fatty acid common in meat, dairy products and egg yolks promotes the survival and growth of human prostate cancer cells. In 2002 Snuffy established the American Institute for Diseases of the Prostate in Charlottesville, Virginia, where he provides clinical care for prostate cancer patients. His Blog, Ask Dr. Myers, is widely visited.
Dr. Robert Princenthal
Robert is a board-certified radiologist with over 25 years of expertise in diagnostic medical imaging. He has interpreted more than 3,000 prostate MRI studies. Bob attended medical school at Penn State College of Medicine. His internship was completed at Hartford Hospital in Harford, Connecticut. A diagnostic radiology residency was completed at Yale University School of Medicine at New Haven Hospital and a fellowship in interventional radiology at the University of California, San Diego. Robert is President of Rolling Hills Radiology in California.
Dr. Mark Scholz
Mark is a board-certified medical oncologist and Medical Director at Prostate Oncology Specialists in Marina Del Rey, California. He also serves as Executive Director of the Prostate Cancer Research Institute. Mark is a co-author with patient Ralph Blum of the book Invasion of the Prostate Snatchers: No More Unnecessary Biopsies, Radical Treatment or Loss of Potency. Mark has advised many patients navigating a regimen of active surveillance along with many men following other interventions and courses of treatment.